Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

61158 Press Releases
DateTitleCompany
28 Jul 11 AllograftPossibilities.org Meets Unmet Need for Consumer-Oriented Information on Tissue Donation, Transplantation on the Internet THE FLETCHER GROUP LLC,
Published by
PR Newswire
28 Jul 11 American Spine Center Has Opened a New, State of the Art, Spine Treatment Facility in Frederick, MD, at 1050 Key Parkway ADVANCED PAIN MANAGEMENT SERVICES,
Published by
PR Newswire
28 Jul 11 Pri-Med Selected to Launch New National Education Initiative on Effective HIV Screening Pri-Med,
Published by
Business Wire
28 Jul 11 RegeneRx Set to Begin Enrolling Phase 2 Dry Eye Trial RegeneRx Biopharmaceuticals Inc.,
Published by
Business Wire
28 Jul 11 University Hospital Wurzburg: The World’s First Heart Patient Treated with Novel MRI Ablation Catheter University Hospital Würzburg,
Published by
Business Wire
28 Jul 11 Viamet Pharmaceuticals and the National Institutes of Health to Jointly Develop Novel Viamet Compound Viamet Pharmaceuticals Inc.,
Published by
Business Wire
28 Jul 11 Capsalus Corp. to Acquire Sales & Marketing Operation of Consumer Genomics Innovator Capsalus Corp.,
Published by
Business Wire
28 Jul 11 BioSante Pharmaceuticals Prices Public Offering of Common Stock BioSante Pharmaceuticals Inc.,
Published by
Business Wire
28 Jul 11 BSD Medical Appoints Mr. Jordan Wittmeier as Director of International MicroThermX® Sales, Further Expanding Its Global Distribution Network BSD Medical Corporation,
Published by
Business Wire
28 Jul 11 NanoString Offers New Tool for Analyzing 25 Leukemia Fusion Genes in a Single Reaction NanoString Technologies Inc.,
Published by
Business Wire
28 Jul 11 Advaxis Immunotherapies Classified as Non-Pathogenic Materials by the CDC in the U.S. and the ZKBS in Germany Advaxis Inc.,
Published by
Business Wire
28 Jul 11 OptumHealth Provides Grant Writing Services to Mental Health Organizations in New Mexico OptumHealth,
Published by
Business Wire
28 Jul 11 EMA ACCEPTS EISAI’S LICENSE EXTENSION APPLICATION FOR ZONEGRAN (ZONISAMIDE) IN EPILEPSY Eisai
28 Jul 11 BYDUREONâ„¢ Reply Submitted to FDA Alkermes Inc.,
Published by
Business Wire
28 Jul 11 Celgene Reports Record Second Quarter 2011 Operating and Financial Results Celgene Corporation,
Published by
Business Wire
28 Jul 11 Yissum Introduces Novel Markers for Brain Cancer Survival Prognosis and a New Treatment Method for the Disease Yissum Research Development Company Ltd.,
Published by
Business Wire
28 Jul 11 Roche’s xCELLigence MP Instrument Used in the First Human Kinome Screen for Dynamic RNA Inhibitor Phenotypes during Cell Proliferation Roche,
Published by
Business Wire
28 Jul 11 Natus Medical Announces 2011 Second Quarter Financial Results Natus Medical Incorporated,
Published by
Business Wire
28 Jul 11 Solazyme and Space NK Sign UK Distribution Agreement for Anti-Aging Skincare Line Algenist Solazyme Inc.,
Published by
Business Wire
28 Jul 11 Allos Therapeutics to Report Second Quarter 2011 Results on August 4, 2011 Allos Therapeutics Inc.,
Published by
Business Wire
28 Jul 11 Boston Therapeutics IpoxynTM Data to be Presented Today at Symposium at Massachusetts General Hospital Boston Therapeutics Inc.,
Published by
Business Wire
28 Jul 11 Histogenics Reports Positive Phase 2 Data for NeoCart Autologous Cartilage Tissue Implant for the Treatment of Knee Cartilage Injury Histogenics Corporation,
Published by
Business Wire
28 Jul 11 Abiomed First Quarter Fiscal 2012 Earnings and Conference Call Notification Abiomed Inc.,
Published by
Business Wire
28 Jul 11 International Stem Cell to Hold Business Update Conference Call on August 10 International Stem Cell Corporation,
Published by
Business Wire
28 Jul 11 Curis Reports Second Quarter 2011 Financial Results Curis Inc.,
Published by
Business Wire
28 Jul 11 Incyte Reports Second Quarter 2011 Financial Results and Provides Update on Key Clinical Programs Incyte Corporation,
Published by
Business Wire
28 Jul 11 Yaupon Therapeutics, Inc. Submits New Drug Application for Proprietary Gel Formulation of Mechlorethamine Hydrochloride Yaupon Therapeutics Inc.,
Published by
Business Wire
28 Jul 11 AmerisourceBergen Reports $0.66 in Diluted EPS for the June Quarter, Up 16% AmerisourceBergen Corporation,
Published by
Business Wire
28 Jul 11 NeuroMetrix Reports Q2 2011 Results NeuroMetrix Inc.,
Published by
Business Wire
28 Jul 11 Medidata Solutions Schedules Second Quarter Earnings Conference Call for August 9, 2011 Medidata Solutions,
Published by
Business Wire
Advertising